Waters (WAT) stock has shown some interesting price movement over the past month, up nearly 6% even as long-term returns remain mixed. Investors may be weighing recent business results and overall sector sentiment at current levels.
See our latest analysis for Waters.
Waters’ share price has bounced back impressively in the last month with a 6.5% gain, though its 1-year total shareholder return remains negative. Momentum is picking up after a 22% share price rise over the past 90 days, which suggests that sentiment around recent performance may be shifting.
If renewed momentum in Waters has you looking for what else is out there, it could be the right time to broaden your sights and discover fast growing stocks with high insider ownership
Yet with shares recovering from recent lows and robust annual earnings growth on display, the key question is whether Waters is still trading below its true worth or if the market is already factoring in future gains.
Waters’ popular narrative suggests its fair value sits slightly above the last close, indicating the latest rally has not yet priced in all upside. Aggressive growth projections and a rising sector profile may be pivotal factors that set this view apart.
The planned combination with BD’s Biosciences and Diagnostic Solutions business is expected to accelerate entry into biologics, precision medicine, and cell/gene therapy markets, segments with expanding analytical needs. This could unlock new addressable markets and provide a multi-year revenue synergy opportunity, directly impacting future revenues and EPS growth.
Curious what bold bets underpin this valuation? The narrative is built on a foundation of double-digit expansion, future-shifting partnerships, and projections that could outpace market norms. Discover which revenue and profit forecasts are fueling this fair value and why the multiple is turning heads. Get the full story behind the numbers.
Result: Fair Value of $355.74 (UNDERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, execution risks from acquisitions and margin pressures tied to trade policies could challenge Waters’ growth outlook if these issues are not managed effectively.
Find out about the key risks to this Waters narrative.
If you think there’s more to the story or want your own hands-on perspective, you can dive into the numbers and shape your narrative in under three minutes. Do it your way
A great starting point for your Waters research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
